Navigation Links
BD Supports the FDA's Proposal to Reclassify Rapid Influenza Tests
Date:8/26/2013

FRANKLIN LAKES, N.J., Aug. 26, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, supports the U.S. Food and Drug Administration's (FDA's) proposed reclassification of rapid influenza detection tests.  A hearing, held on June 13th by FDA's CDRH Microbiology Devices Advisory Committee Meeting, examined the FDA's proposal to reclassify rapid influenza detection tests (RIDTs) currently regulated as Class I devices, into Class II devices.

The recent 2009 flu pandemic has emphasized the poor performance of point-of-care flu tests available at the time. The new performance standards will provide healthcare providers with criteria for evaluating the tests that they use. The proposal would increase performance requirements for RIDTs to attain at least a sensitivity of 90 percent for influenza A and 80 percent for influenza B versus viral culture and/or 80 percent versus polymerase chain reaction (PCR) methods. If these minimum clinical performance criteria are not met, marketed devices will need to be withdrawn from the market one year after the rule is finalized. This proposal culminates years of publications showing that many of the visual read RIDTs had poor sensitivity when compared to viral culture and to reverse transcription PCR methods.

"This proposal is a step in the right direction as physicians and hospitals routinely rely on rapid diagnostic influenza tests to help manage patients that are suspected of having influenza," said Tom Polen, President, BD Diagnostics – Diagnostic Systems. "Raising the standards of rapid influenza tests will provide healthcare providers the right information to guide patient diagnosis and treatment without requiring repeat testing."

BD pioneered the development of a higher performing test
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
2. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
3. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
4. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
5. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
6. Ventana Supports World Patient Safety Day, July 25
7. eCardio Supports the Carolinas HealthCare Foundation Through Grant for Heart Of A Champion Day
8. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
9. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
10. Henry Schein Cares Supports Alliance for Oral Health Across Borders Leadership Event
11. Cardinal Health Supports Future Pharmacists With Nearly $1 Million In Scholarships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 About ... in dryness of eyes due to deficient tear production ... This syndrome is of two types: aqueous tear deficient ... deficient dry eye, lacrimal glands do not produce enough ... eye. Meibomian glands secrete lipids to slow tear evaporation ...
(Date:9/3/2015)... TAMPA, Fla. , Sept. 3, 2015  WellCare ... that Drew Asher , senior vice president and ... Wells Fargo Securities 2015 Healthcare Conference on Wednesday, September ... The presentation will be webcast live. In addition, a ... conclusion of the live broadcast. Both the live broadcast ...
(Date:9/3/2015)... VIEJO, Calif. , Sept. 3, 2015 /PRNewswire/ ... global pharmaceutical company, and AqueSys, Inc. a private ... ocular implants that reduce intraocular pressure (IOP) associated ... into an agreement under which Allergan will acquire ... of the agreement, Allergan will acquire AqueSys for ...
Breaking Medicine Technology:Global Dry Eye Syndrome Market 2015-2019 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6
... IsoRay, Inc. (AMEX: ISR ), a ... medical radioisotope applications for brain cancer, lung cancer, head ... Dwight Babcock, Chairman and Chief Executive Officer, will co-present ... TIME:  5:00 PM EST LINK:   ...
... Africa, Nov. 29, 2011   Leatt Corporation (OTC: ... a neck brace system designed to help prevent potentially ... sports, today announced the formation of an agreement with ... New Zealand. Whites Powersports has more than ...
Cached Medicine Technology:IsoRay, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st 2Leatt Announces Distribution Agreement With Whites Powersports for New Zealand Market 2
(Date:9/4/2015)... ... September 04, 2015 , ... San Francisco cosmetic dentist ... CEREC is a newer method for creating restorations through innovative imaging equipment and ... the need for multiple appointments, CEREC produces restorations with total precision for a ...
(Date:9/4/2015)... ... ... Many consumers are looking for a quick and convenient way to produce a hot remedy ... Cups provide a quick and simple way to brew a hot cup of cold remedy ... a result, they enhance comfort and health. The invention features a novel design that is ...
(Date:9/4/2015)... ... 04, 2015 , ... The conference program for the upcoming ... 9-10, 2015 at the Diplomat Resort & Spa has been announced and is ... at the top of their field and will be presenting sessions such as ...
(Date:9/4/2015)... ... September 04, 2015 , ... Lalonde Gordon ran a 44.64 ... up with victory in the men’s 400 meters final, with an impressive 44.89 seconds ... Championships in San Jose, Costa Rica in August 2015. The 44.64 time is a ...
(Date:9/4/2015)... ... 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has written an ... Pope’s upcoming trip to the United States. , Yisrayl lays out what he says is ... and society is. Yisrayl also provides the meaning of his own name and describes what ...
Breaking Medicine News(10 mins):Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... Thirty-year Communications Veteran Tasked with Expanding Opportunities for ... Breast Cancer Organization, DALLAS, Dec. 12 ... communications professionals, today was named chief marketing,officer for ... largest grassroots,network of breast cancer survivors and activists., ...
... Technologies Inc.,(TSX: NDQ), a developer of real-time ... the operating room, today announced that it ... North American Medical Imaging Product of,the Year ... Novadaq,company executives were recognized during Frost & ...
... Cross volunteer,Krysta Leigh Meinzer is featured in "Cause ... college network, profiling standout student,activists on college campuses ... an episode of the show, which is broadcast ... Think.MTV.com., (Photo: http://www.newscom.com/cgi-bin/prnh/20071212/DC09732 ), ...
... educate that drugs such as morphine are more than just ... -- Many cancer patients endure unnecessary suffering when they resist ... the use of these drugs signifies imminent death, a new ... range of available opioids in order to successfully manage pain ...
... 2007) A new study confirms that chronic kidney ... events in diabetic patients with damage to the large ... drug pioglitazone may help to lower this risk, reports ... , "The data confirm that chronic kidney disease is ...
... Minn. -- When a vaccine to prevent shingles was ... Administration recommended the vaccine for people age 60 and ... the vaccines cost and the perception that shingles primarily ... some physicians undecided about whether healthy adults need the ...
Cached Medicine News:Health News:Susan G. Komen for the Cure Names Tim Doke Chief Marketing Officer 2Health News:Novadaq's SPY Imaging System named Product of the Year by Frost and Sullivan 2Health News:Novadaq's SPY Imaging System named Product of the Year by Frost and Sullivan 3Health News:Novadaq's SPY Imaging System named Product of the Year by Frost and Sullivan 4Health News:Red Cross Blood Donor and Volunteer Featured on mtvU's 'CAUSE EFFECT' 2Health News:Cancer Patients Hold Fast to Belief That Opioids Mean Death 2Health News:Pioglitazone lowers cardiovascular risk in diabetic patients with kidney disease 2Health News:Mayo Clinic article offers data about shingles virus 2
... generation access device - XPOSE 4 - ... The XPOSE 4 Device is designed to ... surgery and to easily position and access ... both apical and non-apical placement on the ...
... system is an intuitive, all-in-one endoscopic ... minimize the scarring and risk of ... Incorporating an enhanced, ergonomic handle design ... obstructions, this new device is intended ...
... includes three major components: Blood pump, Cannulae, ... Driver. This system provides partial or total ... conventional therapy, is unable to maintain adequate ... support, blood flows from the natural heart ...
... TISSEEL VH Fibrin Sealant has been shown ... surgical repair. Containing uniform, reproducible concentrations of ... simulates the final stage of the coagulation ... clot that firmly adheres to connective tissue ...
Medicine Products: